While the initial approvals were for type 2 diabetes and chronic weight management, the data emerging from both clinical studies and real-world observation is compelling enough that many endocrinologists and reproductive specialists are already incorporating it into their treatment approaches for women with polycystic ovary syndrome
MASH is very common and represents a major public health issue because it increases the risk of liver-related complications, such as cirrhosis and hepatocellular carcinoma, as well as cardiovascular events, chronic kidney disease, type 2 diabetes, extrahepatic cancers, and severe infections
Some providers offer vials containing different total amounts of medication, with pricing that reflects the quantity
While PIONEER 6 demonstrated cardiovascular safety (non-inferiority), and the SOUL trial reported significant reductions in MACE, the oral formulation does not yet carry a formal FDA indication for cardiovascular risk reduction in high-risk adults with type 2 diabetes